% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • larrystone13 larrystone13 Nov 21, 2012 11:00 AM Flag

    Seeking " SRPT Will Easily Approach $75 " linked

    Wednesday's Bio-Pharma Catalyst Trades And Watch List
    November 21, 2012
    I think it's a good bet Sarepta gets the early approval, which would likely cause the stock price to explode from its current price level of $27 a share -- I can easily see a stock price approaching $75 or higher here.
    DMD is a very rare disease that affects mainly children -- a potential cure for any form of MD would be on par with Jonas Salk's discovery of the Polio vaccine in my strong opinion.
    Between the 5 analysts that cover the stock, the mean price target is a whopping $44.20.

60.98-1.26(-2.02%)Sep 29 4:00 PMEDT